tert-Butyl methyl ether → (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5-bromo-2-(methylsulfonyl)pyrimidin-4-yl]methyl}-4-methyl-1,3-oxazolidin-2-one
反応式
[F:1][C:2]([F:31])([F:30])[C:3]1[CH:4]=[C:5]([C@H:13]2[O:17][C:16](=[O:18])[N:15]([CH2:19][C:20]3[C:25]([Br:26])=[CH:24][N:23]=[C:22](SC)[N:21]=3)[C@H:14]2[CH3:29])[CH:6]=[C:7]([C:9]([F:12])([F:11])[F:10])[CH:8]=1.[S:32]([O-:37])(O[O-])(=O)=[O:33].[K+].[K+].[CH3:40]OC(C)(C)C>C(#N)C.O>[F:12][C:9]([F:10])([F:11])[C:7]1[CH:6]=[C:5]([C@H:13]2[O:17][C:16](=[O:18])[N:15]([CH2:19][C:20]3[C:25]([Br:26])=[CH:24][N:23]=[C:22]([S:32]([CH3:40])(=[O:37])=[O:33])[N:21]=3)[C@H:14]2[CH3:29])[CH:4]=[C:3]([C:2]([F:1])([F:31])[F:30])[CH:8]=1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
To a suspension of (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[5-bromo-2-(methylsulfanyl)pyrimidin-4-yl]methyl}-4-methyl-1,3-oxazolidin-2-one (INTERMEDIATE 8, 10 g, 18.86 mmol) in acetonitrile (25 mL) and water (25 mL) was added potassium peroxymonosulfate (27.8 g, 45.3 mmol). After it was stirred at room for 14 hours, LCMS showed complete conversion of the starting material. It was distributed between water (200 mL) and t-butyl methyl ether (300 mL). The organic layer was washed with water (200 mL) and brine, dried over sodium sulfate, filtered and the filtrate concentrated to get the title compound (10.2 g, 96% yield) as a brightly white solid. LCMS (M+H)+: 564.05. 1H NMR (CDCl3, 500 MHz): δ 8.99 (s, 1H), 7.93 (s, 1H), 7.84 (s, 2H), 6.02 (d, 8.5 Hz, 1H), 5.14 (d, 18.5 Hz, 1H), 4.56 (m, 1H), 4.42 (d, 18.0 Hz, 1H), 3.37 (S, 3H), 0.86 (d, 6.5 Hz, 3H).
後処理
- washThe organic layer was washed with water (200 mL) and brine
- dry with materialdried over sodium sulfate
- filtrationfiltered
- concentrationthe filtrate concentrated
出典と根拠
- ORDレコード
- ord-bbaaa807f5c24d0e9cdc9ab5afcdcf02
- 出典データセット
- uspto-grants-2016_05
- 特許番号
- US09353101B2
反応ノート
読み込み中…